Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 171

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma

Cheng, Yao, Zhao, Pengxuan, Wu, Shuangping, Yang, Tan, Chen, Yan, Zhang, Xiaojuan, He, Chuanchuan, Zheng, Chao, Li, Kelin, Ma, Xiang, Xiang, Guangya·2018·International Journal of Pharmaceutics

Abstract

ABSTRACT Hepatocellular carcinoma (HCC) continues to be a leading cause of cancer related death in the world. Conventional chemotherapeutic agents such as cisplatin (CDDP) have an unsatisfactory efficacy on HCC due to the poor response, severe toxicity and drug resistance. Curcumin (CUR) could improve the chemosensitivity of HCC to chemotherapy drugs by regulating a variety of signaling pathways. Herein, we describe a combination strategy using co‐loaded liposomes to effectively deliver and release CDDP and curcumin (CUR) to HCC for overcoming the unsatisfactory clinical outcome of CDDP monotherapy. In the study, CDDP and CUR co‐loaded liposomes (CDDP/CUR‐Lip) were prepared by a reverse microemulsion and film dispersion method and their average particle size 294.6±14.8nm with uniform size distribution. In vitro study showed that the nano sized CDDP/CUR‐Lip could synchronously release both CDDP and CUR to achieve the synergistic effect against HCC cells based on the optimal ratio (1:8) of both drugs. Compared with free drug or encapsulated mono‐drug therapy, CDDP/CUR‐Lip demonstrated the higher anti‐tumor activity in vitro against HepG2 cells with the IC50 of 0.62&mgr;M. In addition, CDDP/CUR‐Lip also increased intracellular ROS level during the HCC cells treatment. Furthermore, compared with single drug formulation, CDDP/CUR‐Lip showed the elongated retention time (t1/2=2.38h) and improved antitumor effect in both mouse hepatoma H22 and human HCC HepG2 xenograft models with reduced side effects. In conclusion, CDDP/CUR‐Lip provide an attractive and potential strategy to attain synergistic effect of CDDP and CUR for the treatment of HCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijpharm.2018.05.007

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 171

Metadata

Authors
Cheng, Y., Zhao, P., Wu, S., Yang, T., Chen, Y., Zhang, X., He, C., Zheng, C., Li, K., Ma, X., & Xiang, G.
Venue
International Journal of Pharmaceutics
Publisher
Elsevier BV
Published
2018-07
Volume
545
Issue
1-2
Pages
261-273
ISSN
0378-5173 (ISSN-L)
OpenAlex
W2802252398
Cited by
171
References
1
FWCI
4.57
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma. https://app.cochat.ai/papers/10.1016/j.ijpharm.2018.05.007
The paper
Cheng, Y., Zhao, P., Wu, S., Yang, T., Chen, Y., Zhang, X., He, C., Zheng, C., Li, K., Ma, X., & Xiang, G. (2018). Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2018.05.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.